MEDVi QUAD vs BlueChew Gold: Both Have 4 Ingredients, but Only One Has 4 That Actually Treat ED

This comparison is simpler than it looks. QUAD and BlueChew Gold share three of the same ingredients. They split on the fourth. That fourth ingredient is the entire decision. We dug into the published research on both to figure out which one actually delivers what it promises.

The only question that matters: vardenafil or oxytocin?

Strip away the branding and you're looking at two products with the same base: sildenafil for fast blood flow, tadalafil for the 36-hour window, apomorphine for central arousal. These three are identical between QUAD and BlueChew Gold. The entire comparison comes down to what each product chose as its fourth ingredient.

QUAD chose vardenafil. BlueChew Gold chose oxytocin. These are not equivalent choices.

Vardenafil: the case is straightforward

Vardenafil is the active ingredient in Levitra, marketed since 2003. It's the third major PDE5 inhibitor — same drug class as sildenafil (Viagra) and tadalafil (Cialis). It has hundreds of published clinical studies demonstrating efficacy for erectile dysfunction across all severity levels. Among the three PDE5 inhibitors, vardenafil consistently shows the fastest time to onset. It's FDA-approved. It's well understood. Adding it to a formula that already contains sildenafil and tadalafil gives you coverage across all three PDE5 pathways.

There's nothing exotic or speculative about this choice. It's a third proven ED medication added to two other proven ED medications.

Oxytocin: the case falls apart quickly

Oxytocin is a neuropeptide primarily known for its role in social bonding, trust, and maternal behavior. BlueChew markets it as supporting "emotional connection" and "deeper intimacy." That language is doing a lot of heavy lifting, because the clinical reality is less compelling.

Problem 1: No ED evidence. Oxytocin has never been approved for treating erectile dysfunction. There are no published randomized controlled trials showing that oxytocin improves erection quality, firmness, or reliability. Some early-stage research explores oxytocin's role in sexual behavior broadly, but there's a wide gap between "may play a role in sexual behavior" and "treats erectile dysfunction."

Problem 2: It barely absorbs sublingually. This is the bigger issue. Published research puts sublingual oxytocin bioavailability at approximately 4.5%, with "10-fold variation" between individuals. The researchers explicitly concluded that sublingual delivery "would not seem a reliable route" for administering oxytocin therapeutically. Even intranasal delivery — the standard research method — only achieves 11% bioavailability.

So you have an ingredient that isn't proven for ED, and even if it were, the delivery method used by BlueChew Gold fails to get meaningful amounts into the bloodstream. That's a rough combination.

Format: liquid vs dissolving tablet

QUAD uses a sublingual liquid. BlueChew Gold uses a rapidly dissolving tablet (RDT) that you place under or on your tongue.

Both approaches skip the digestive system, which is the primary advantage over swallowed pills. But there's a practical difference in absorption consistency. With a liquid, the active ingredients are already dissolved — absorption begins the moment the liquid contacts the sublingual membrane. With a dissolving tablet, the drug first needs to dissolve in your saliva before absorption can begin. BlueChew Gold's RDT dissolves quickly, but there's been user feedback about chalky texture and inconsistent dissolution.

There's also the blue tongue issue. Multiple BlueChew Gold reviews mention that the tablet leaves a visible blue residue on the tongue — not exactly subtle if you're trying to be discreet about taking it. QUAD's liquid doesn't have this problem.

Neither product has Rugiet Ready's melting problem (since neither is a solid troche that needs refrigeration), so both are fine for portability.

Pricing: BlueChew Gold wins on cost, QUAD wins on value

Let's not dance around it: BlueChew Gold is cheaper. Significantly cheaper.

If budget is your primary constraint, BlueChew Gold is the more affordable option. There's no getting around that.

But the value question is different from the price question. BlueChew Gold's cheaper price buys you three proven ED ingredients plus one that doesn't meaningfully contribute. QUAD's higher price buys you four proven ED ingredients — all of which have demonstrated clinical efficacy for erectile dysfunction.

Put it this way: you're paying ~$52 more per month with QUAD. For that, you're getting vardenafil (the fastest-onset PDE5 inhibitor, FDA-approved for ED) instead of oxytocin (4.5% sublingual bioavailability, no ED evidence). Whether that $52 is worth it depends on how much you value having every ingredient in your treatment actually contribute to treating the condition.

BlueChew also has the weight of brand recognition behind it — over 4 million users across their product line. That matters for some men. Brand familiarity doesn't change the pharmacology, but it does change the comfort level of trying something new.

What BlueChew Gold does well

Credit where it's due. BlueChew Gold isn't a bad product — its three core ingredients (sildenafil, tadalafil, apomorphine) are the same proven foundation as Rugiet Ready and QUAD. For most men, those three ingredients will produce meaningful improvement in erectile function. The product is affordable, accessible through a massive telehealth platform, and comes from a brand that millions of men already trust.

If you strip out the oxytocin and evaluate BlueChew Gold purely on its three proven ingredients, it's essentially a more affordable version of Rugiet Ready's formula in a tablet format instead of a troche. For men who are price-sensitive and primarily need sildenafil + tadalafil + apomorphine, BlueChew Gold delivers that at a lower price point than both Rugiet and QUAD.

The issue isn't that BlueChew Gold doesn't work. The issue is that its marketing suggests four ingredients are better than three, when in reality only three of its four ingredients are contributing to the therapeutic effect. If BlueChew marketed Gold honestly as a "3-ingredient formula with an oxytocin bonus," the conversation would be different. But they position it as a true 4-ingredient product competing head-to-head with QUAD, and on those terms, the oxytocin claim doesn't survive scrutiny.

Who should choose which

Our verdict

If you're choosing between these two products specifically because both advertise "4 ingredients," then the comparison favors QUAD decisively. QUAD's vardenafil is a genuine, proven, FDA-approved ED medication. BlueChew Gold's oxytocin is not.

If you're choosing purely on price, BlueChew Gold is cheaper, and its three proven ingredients will likely produce results for most men.

If you're choosing on ingredient science — on the principle that you want every single compound in your treatment to have evidence behind it — QUAD is the clear winner. And for men who've tried dual PDE5 combinations without ideal results, the addition of vardenafil as a third pathway is a genuine pharmacological advantage, not just a label change.

Frequently Asked Questions

More Comparisons